Financials

News Ideas Technicals Forecast

1J5 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to HYPHENS PHARMA operating, investing, and financing activities

1J5 free cash flow for H2 23 is 3.41 M SGD. For 2023, 1J5 free cash flow was 5.53 M SGD and operating cash flow was 5.83 M SGD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: SGD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—